Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get your Portfolio automatically emailed to you up to 4 times a day with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Biontech Se ADR (BNTX)

Biontech Se ADR (BNTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 21,983,882
  • Shares Outstanding, K 237,715
  • Annual Sales, $ 18,238 M
  • Annual Income, $ 9,940 M
  • 60-Month Beta 0.23
  • Price/Sales 3.12
  • Price/Cash Flow 2.24
  • Price/Book 1.03
Trade BNTX with:

Options Overview Details

View History
  • Implied Volatility 42.00% ( +1.97%)
  • Historical Volatility 27.46%
  • IV Percentile 88%
  • IV Rank 62.99%
  • IV High 48.79% on 10/27/23
  • IV Low 30.45% on 03/29/23
  • Put/Call Vol Ratio 0.33
  • Today's Volume 2,848
  • Volume Avg (30-Day) 1,204
  • Put/Call OI Ratio 0.91
  • Today's Open Interest 38,983
  • Open Int (30-Day) 44,035

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 14 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/23
See More
  • Average Estimate 2.64
  • Number of Estimates 6
  • High Estimate 3.29
  • Low Estimate 1.96
  • Prior Year 9.46
  • Growth Rate Est. (year over year) -72.09%

Price Performance

See More
Period Period Low Period High Performance
1-Month
87.90 +5.79%
on 03/04/24
97.50 -4.63%
on 03/11/24
+1.32 (+1.44%)
since 02/16/24
3-Month
87.90 +5.79%
on 03/04/24
114.69 -18.92%
on 01/02/24
-10.58 (-10.22%)
since 12/18/23
52-Week
87.90 +5.79%
on 03/04/24
136.91 -32.08%
on 03/22/23
-36.65 (-28.27%)
since 03/17/23

Most Recent Stories

More News
3 Stocks Down 30% or More This Year That Wall Street Expects to Skyrocket in 2024

Analysts think these beaten-down stocks could rebound strongly in the new year.

MRK : 121.44 (-0.07%)
PFE : 27.72 (-0.79%)
BNTX : 92.99 (+0.55%)
JD : 27.85 (+1.46%)
MRNA : 104.26 (+0.39%)
BioNTech Se (BNTX) Q3 2023 Earnings Call Transcript

BNTX earnings call for the period ending September 30, 2023.

BNTX : 92.99 (+0.55%)
3 No-Brainer Stocks to Buy for Under $100 Right Now

A couple of these stocks might not be available for under $100 for too much longer.

AZN : 65.85 (-0.69%)
BNTX : 92.99 (+0.55%)
NVS : 95.92 (-1.39%)
Is BioNTech Stock a Buy Now?

Or is it too late to get in on the company after its coronavirus-related success?

PFE : 27.72 (-0.79%)
BNTX : 92.99 (+0.55%)
Why Pancreatic Cancer is No Longer a Death Sentence: Emerging Therapies to Watch

USA News Group – Despite being a relatively rare form of cancer, pancreatic cancer remains one of the deadliest in the oncology field, the third leading cause of cancer death in the USA. Still not fully...

ONCY : 1.0400 (+5.17%)
ONC.TO : 1.42 (+5.97%)
LLY : 762.66 (+1.13%)
RHHBY : 32.1800 (-1.41%)
BNTX : 92.99 (+0.55%)
ME : 0.4709 (+6.11%)
Fighting the Silent Killer: Innovative Therapies for Pancreatic Cancer on the Rise

EQNX::TICKER_START (NASDAQ:ONCY),(TSX:ONC),(OTCQX:RHHBY),(NASDAQ:BNTX),(NASDAQ:ME) EQNX::TICKER_END

LLY : 762.66 (+1.13%)
ONCY : 1.0400 (+5.17%)
ONC.TO : 1.42 (+5.97%)
RHHBY : 32.1800 (-1.41%)
BNTX : 92.99 (+0.55%)
ME : 0.4709 (+6.11%)
Which Is the Better Long-Term Hold for Investors: Pfizer or Roche?

The venerable pharmaceutical companies' shares have slumped this year.

BMY : 51.59 (-1.43%)
SGEN : 228.74 (-0.07%)
REGN : 959.92 (-0.47%)
BNTX : 92.99 (+0.55%)
PFE : 27.72 (-0.79%)
RHHBY : 32.1800 (-1.41%)
Biotech Companies Make Further Progress in Promising Pancreatic Cancer Treatment Research

/PRNewswire/ -- USA News Group - According to the American Cancer Society in its Cancer Facts & Figures 2023 report, the five-year survival rate for pancreatic...

ONC.TO : 1.42 (+5.97%)
BNTX : 92.99 (+0.55%)
ONCY : 1.0400 (+5.17%)
SGEN : 228.74 (-0.07%)
MYGN : 21.63 (+2.22%)
ILMN : 130.14 (+1.89%)
Biotech Companies Make Further Progress in Promising Pancreatic Cancer Treatment Research

EQNX::TICKER_START (NASDAQ:ONCY),(TSX:ONC),(NASDAQ:BNTX),(NASDAQ:SGEN),(NASDAQ:MYGN),(NASDAQ:ILMN) EQNX::TICKER_END

ONCY : 1.0400 (+5.17%)
ONC.TO : 1.42 (+5.97%)
SGEN : 228.74 (-0.07%)
MYGN : 21.63 (+2.22%)
ILMN : 130.14 (+1.89%)
BNTX : 92.99 (+0.55%)
The Fight Against Pancreatic Cancer Just Gained a New Ally with $200M VC Firm

VANCOUVER – USA News Group – A new cancer-focused venture capital firm is making headlines, having debuted with $200 million in funding from prominent individuals and institutions such as MIT, Memorial...

AAPL : 173.72 (+0.64%)
NYT : 43.27 (-0.78%)
ONCY : 1.0400 (+5.17%)
ONC.TO : 1.42 (+5.97%)
MACK : 14.72 (-0.14%)
INCY : 57.34 (-1.76%)
MRTX : 58.70 (-0.17%)
BNTX : 92.99 (+0.55%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 80% Sell with a Weakening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

BioNTech SE is a biotechnology company. It develops and commercializes immunotherapies for cancer and other diseases. BioNTech SE is based in Mainz, Germany.

See More

Key Turning Points

3rd Resistance Point 96.48
2nd Resistance Point 95.25
1st Resistance Point 94.12
Last Price 92.99
1st Support Level 91.75
2nd Support Level 90.52
3rd Support Level 89.39

See More

52-Week High 136.91
Fibonacci 61.8% 118.19
Fibonacci 50% 112.41
Fibonacci 38.2% 106.62
Last Price 92.99
52-Week Low 87.90

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar